Werbung
Werbung

ATRC

ATRC logo

AtriCure, Inc.

42.49
USD
Gesponsert
+0.72
+1.74%
08. Jan., 15:58 UTC -5
Geschlossen
exchange

Nach-Markt

42.41

-0.08
-0.20%

ATRC Ergebnisberichte

Positives Überraschungsverhältnis

ATRC übertreffen die 30 der letzten 40Schätzungen.

75%

Nächster Bericht

Datum des nächsten Berichts
10. Feb. 2026
Estimate for Q4 25 (Revenue/ EPS)
$142.05M
/
-$0.09
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+5.80%
/
+800.00%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+14.30%
/
+12.50%

AtriCure, Inc. earnings per share and revenue

On 29. Okt. 2025, ATRC reported earnings of -0.01 USD per share (EPS) for Q3 25, beating the estimate of -0.11 USD, resulting in a 91.46% surprise. Revenue reached 134.27 million, compared to an expected 133.88 million, with a 0.29% difference. The market reacted with a -3.81% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 11 analysts forecast an EPS of -0.09 USD, with revenue projected to reach 142.05 million USD, implying an increase of 800.00% EPS, and increase of 5.80% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Neogen Corp
Report Date
08. Jan. 2026 For Q2 26
Estimate
$0.05
Aktuell
$0.10
Überraschung
+78.25%
logo
Tilray Brands, Inc. Common Stock
Report Date
08. Jan. 2026 For Q2 26
Estimate
-$0.20
Aktuell
-$0.41
Überraschung
-100.98%
FAQ
For Q3 2025, AtriCure, Inc. reported EPS of -$0.01, beating estimates by 91.46%, and revenue of $134.27M, 0.29% above expectations.
The stock price moved down -3.81%, changed from $35.44 before the earnings release to $34.09 the day after.
The next earning report is scheduled for 10. Feb. 2026.
Based on 11 analysts, AtriCure, Inc. is expected to report EPS of -$0.09 and revenue of $142.05M for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung